Nichi-Iko Pharmaceutical Co., Ltd. (4541.T)
ValueMarkers Composite Index
DCF data not available
Nichi-Iko Pharmaceutical Co., Ltd. (4541.T) — VMCI valuation read
4541.T prints VMCI 71/100 inside the Healthcare sector, where the median sits at 50. The 21-point above-median delta is the cleanest single-number summary of Nichi-Iko Pharmaceutical Co., Ltd.'s composite stance, and in the mid-cap bucket it places the share ahead of the typical peer on the five-pillar mix.
On 4541.T, the SEC EDGAR Form 4 stream shows no insider buys or sells in the past 30 days. Quiet tapes happen; they just remove a signal that bull and bear cases sometimes lean on for confirmation.
**Investor frame.** 4541.T trades at 18.0x earnings, 0% above the Healthcare median of 18.0x; that is the value line. ROIC of 10.0% sits 0.0pp above the Healthcare median (10.0%); that is the quality line. net debt to EBITDA of -1.0x leaves covenant headroom; that is the risk line for Nichi-Iko Pharmaceutical Co., Ltd. on the trailing financials.
4541.T fell 2.0% over the trailing 7 days, with a -15.2% read on a 30-day basis.
Nichi-Iko Pharmaceutical Co., Ltd. manufactures, sells, imports, and distributes various pharmaceutical products. The company operates through two segments, Sagent Group and Nichi-Iko Group. It primarily focuses on the production of generic drugs. The company offers antidiabetic agents, antacids, antireflux agents, beta-blocker, hypnotic and sedative, angiotensin ? antagonist, angiotensin ? antagonist/diuretic combination, dyslipidaemic agent, and calcium antagonist products. It also provides treatments for circulatory, digestive, respiratory, central and peripheral nervous systems, and others. In addition, the company engages in the packaging design business. Further, it exports its products. The company was formerly known as Nihon Iyakuhin Kogyo Co., Ltd. and changed its name to Nichi-Iko Pharmaceutical Co., Ltd. in 2005. Nichi-Iko Pharmaceutical Co., Ltd. was incorporated in 1947 and is headquartered in Toyama, Japan.
Related Stocks in Healthcare
Top peers ranked by VM Score. Compare valuation, quality, and risk metrics across the sector.